ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

GERN Geron Corp

4,49
0,00 (0,00%)
19 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Geron Corp GERN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 4,49 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
4,49
mais cotações »

Notícias Recentes

Data Hora Fonte Título
06/06/202422:58BWGeron Announces FDA Approval of RYTELO™ (imetelstat), a..
16/05/202417:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
02/05/202408:00BWGeron Corporation Reports First Quarter 2024 Financial..
25/04/202417:30BWGeron to Announce First Quarter 2024 Financial Results on..
18/04/202417:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
03/04/202417:30BWGeron to Participate at Upcoming Investor Conferences in..
19/03/202410:07BWGeron Corporation Announces Pricing of $150 Million..
14/03/202416:54BWGeron Announces FDA Oncologic Drugs Advisory Committee Votes..
28/02/202409:05BWGeron Corporation Reports Business Highlights and Fourth..
22/02/202418:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
14/02/202418:30BWGeron to Announce Fourth Quarter and Full-Year 2023..
18/01/202418:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
12/01/202410:30BWGeron to Participate in the B. Riley Securities Virtual..
21/12/202318:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
11/12/202318:15BWGeron Announces IMerge Phase 3 Presentations at ASH..
06/12/202310:00BWGeron Announces Fifty Percent Enrollment in the Phase 3..
04/12/202307:00BWGeron Announces Publication in The Lancet of Results from..
28/11/202310:00BWGeron Corporation Announces Appointment of Gaurav Aggarwal,..
16/11/202318:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
07/11/202318:30BWGeron to Participate at Upcoming Investor Conferences in..
02/11/202310:00BWGeron IMerge Phase 3 Presentations at Upcoming ASH Annual..
02/11/202309:00BWGeron Corporation Reports Business Highlights and Third..
26/10/202317:30BWGeron to Announce Third Quarter 2023 Financial Results on..
19/10/202317:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
29/09/202309:00BWGeron Announces EMA Validation of Marketing Authorization..
12/09/202310:23IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
11/09/202317:30BWGeron Announces Appointment of Michelle Robertson as..
07/09/202309:00BWGeron Announces Data Presentations from IMerge Phase 3..
05/09/202317:30BWGeron to Participate in the Baird 2023 Global Healthcare..
22/08/202309:00BWGeron Announces PDUFA Date for Imetelstat NDA in Lower Risk..
21/08/202309:00BWGeron Announces FDA Acceptance of New Drug Application for..
17/08/202317:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
03/08/202317:05BWGeron Corporation Reports Business Highlights and Second..
27/07/202317:30BWGeron to Announce Second Quarter 2023 Financial Results on..
20/07/202317:30BWGeron Reports Inducement Grants Under Nasdaq Listing Rule..
29/06/202309:30BWGeron Announces U.S. Expanded Access Protocol for Imetelstat..
22/06/202317:30BWGeron Reports Inducement Grant Under Nasdaq Listing Rule..

Seu Histórico Recente

Delayed Upgrade Clock